Author:
Alifia Nur Ayusma ,Widiastuti Ani,Triwidodo Arwiyanto
Abstract
Bacterial leaf blight, caused by the bacterium Xanthomonas oryzae pv. oryzae (Xoo), is an important disease of rice and can cause yield losses of 10-50%. Efforts to control bacterial leaf blight in rice using eucalyptus oil and citronella oil have not been widely reported. This study aims to evaluate the potential inhibition of eucalyptus oil and citronella oil against X. oryzae pv. oryzae isolate code BaK_2 in vitro, focusing on X. oryzae pv. oryzae virulence factors. The virulence factor assay consisted of biofilm formation, exopolysaccharide (EPS) production and motility. The results showed that eucalyptus oil and citronella oil could inhibit the growth of X. oryzae pv. oryzae in vitro. The minimum inhibitory concentration (MIC) was 15% for eucalyptus oil and 5% for citronella oil. Virulence factor tests showed that eucalyptus oil and citronella oil had no significant effect on biofilm formation, but could reduce EPS formation and limit the movement of X. oryzae pv. oryzae by both swimming motility and motility.
Publisher
The Indonesian Phytopathological Society
Reference23 articles.
1. Anonim. 2007. Xanthomonas oryzae. EPPO Bulletin. 37:543–553. DOI: https://doi.org/10.1111/j.1365-2338.2007.01162.x.
2. Ansari TH, Ahmed M, Ara A, Khan MA, Mian MS, Zahan QS, Tomita M. 2018. Yield loss assessment of rice due to bacterial blight at different resistance levels. Bangladesh Journal Plant Pathology. 34:71–76.
3. Antar A, Lee MA, Yoo Y, Cho MH, Lee SW. 2020. PXO_RS20535, encoding a novel response regulator, is required for chemotactic motility, biofilm formation, and tolerance to oxidative stress in Xanthomonas oryzae pv. oryzae. Pathogens. 9(11):1–18. DOI: https://doi.org/10.3390/pathogens9110956.
4. Badan Pusat Statistik. 2023. Luas Panen, Produksi, dan Produktivitas Padi Menurut Provinsi 2020-2022. . [diakses 02 Januari 2023].
5. Chouhan S, Sharma K, Guleria S 2017. Antimicrobial activity of some essential oils – present status and future perspectives. Medicines. 4(3):1–21. DOI: https://doi.org/10.3390/medicines4030058.